Details for Patent: 11,058,677
✉ Email this page to a colleague
Which drugs does patent 11,058,677 protect, and when does it expire?
Patent 11,058,677 protects XIIDRA and is included in one NDA.
This patent has twenty-nine patent family members in twenty countries.
Drugs Protected by US Patent 11,058,677
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Bausch And Lomb Inc | XIIDRA | lifitegrast | SOLUTION/DROPS;OPHTHALMIC | 208073-001 | Jul 11, 2016 | AB | RX | Yes | Yes | ⤷ Subscribe | ⤷ Subscribe | Y | ⤷ Subscribe | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 11,058,677
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Australia | 2013361579 | ⤷ Subscribe | |||
Brazil | 112015014367 | ⤷ Subscribe | |||
Canada | 2894170 | ⤷ Subscribe | |||
China | 104955453 | ⤷ Subscribe | |||
Denmark | 2934510 | ⤷ Subscribe | |||
Eurasian Patent Organization | 028008 | ⤷ Subscribe | |||
Eurasian Patent Organization | 201591180 | ⤷ Subscribe | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |